股神经阻滞与静脉芬太尼用于急诊髋部骨折疼痛的随机双盲临床试验
该单中心随机双盲试验纳入104例影像学确诊髋部骨折的成人急诊患者,比较超声引导股神经阻滞(20 mL 0.5%布比卡因)与静脉芬太尼(1 μg/kg)的镇痛效果。主要终点20分钟疼痛评分变化方面,股神经阻滞组中位下降4分(IQR 3-5),芬太尼组下降2分(IQR 2-3),中位差2分(95%CI 1-2)。4小时内补救镇痛率股神经阻滞组21.1%,芬太尼组61.5%;不良事件仅见于芬太尼组,包括恶心23%、头晕15%、头痛9.6%、低血压5.7%,股神经阻滞组无相关并发症。认知障碍亚组分析显示股神经阻滞疗效一致。
要点
- 髋部骨折成人急诊患者,超声引导股神经阻滞(20 mL 0.5%布比卡因)20分钟疼痛中位下降4分(IQR 3-5),静脉芬太尼(1 μg/kg)下降2分(IQR 2-3),中位差2分(95%CI 1-2)。
- 4小时内需补救镇痛者股神经阻滞组21.1%,芬太尼组61.5%。
- 不良事件仅见于芬太尼组:恶心23%、头晕15%、头痛9.6%、低血压5.7%;股神经阻滞组无相关并发症报告。
- 认知障碍患者亚组分析显示股神经阻滞疗效一致。
适用人群与场景
- 急诊科就诊、影像学确诊髋部骨折的成人患者。
诊断标准与关键阈值
- 疼痛评估采用数字疼痛评分量表或晚期痴呆疼痛评估量表(PAINAD),依据认知状态选择。
处置流程与药物剂量
- 超声引导股神经阻滞组:20 mL 0.5%布比卡因。
- 静脉芬太尼组:1 μg/kg。
- 为保持盲法,每组患者均接受模拟另一治疗的安慰剂注射。
研究设计与关键结果
- 单中心随机双盲临床试验,纳入104例影像学确诊髋部骨折的成人急诊患者,比较超声引导股神经阻滞(20 mL 0.5%布比卡因)与静脉芬太尼(1 μg/kg)。
- 主要终点20分钟疼痛评分变化:股神经阻滞组中位下降4分(IQR 3-5),芬太尼组下降2分(IQR 2-3),中位差2分(95%CI 1-2)。
- 次要终点4小时内补救镇痛率:股神经阻滞组21.1%,芬太尼组61.5%。
- 不良事件仅见于芬太尼组:恶心23%、头晕15%、头痛9.6%、低血压5.7%;股神经阻滞组无相关并发症报告。
- 认知障碍患者亚组分析显示股神经阻滞疗效一致。
证据类型、等级与局限
- 证据类型:单中心随机双盲临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与静脉芬太尼相比,股神经阻滞镇痛更优、副作用更少、补救阿片需求更低。
- 作者认为,股神经阻滞在认知障碍患者中显示出有效且安全的疼痛控制。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hip fractures frequently cause severe pain and functional decline in adults presenting to emergency departments (EDs). Although intravenous (IV) opioids are widely used for pain control, their use may be limited by adverse effects, especially in patients with comorbidities or cognitive impairment. Ultrasound-guided femoral nerve block (FNB) offers a regional analgesic technique that may provide effective pain relief while reducing opioid-related complications. However, comparative randomized trials in the ED setting remain limited.
METHODS: In this single-center, randomized, double-blind clinical trial, adult patients with radiologically confirmed hip fractures were assigned to receive either ultrasound-guided FNB (20 mL 0.5 % bupivacaine) or IV fentanyl (1 μg/kg). To preserve blinding, patients in each group received a placebo injection mimicking the alternative treatment. Pain severity was measured at baseline and 20 min post-intervention using the Numeric Pain Rating Scale or the Pain Assessment in Advanced Dementia Scale (PAINAD), based on cognitive status. The primary outcome was change in pain score at 20 min. Secondary outcomes included rescue analgesia requirement within four hours and adverse events.
RESULTS: A total of 104 patients were enrolled and randomized. The FNB group experienced greater median pain reduction compared to the fentanyl group (4 [IQR 3-5] vs. 2 [IQR 2-3]; median difference: 2, 95 % CI: 1-2). Rescue analgesia was required in 21.1 % of FNB patients versus 61.5 % in the fentanyl group. Adverse events were observed only in the fentanyl group, including nausea (23 %), dizziness (15 %), headache (9.6 %), and hypotension (5.7 %). No FNB-related complications were reported. Subgroup analysis showed consistent efficacy among cognitively impaired patients.
CONCLUSION: FNB resulted in superior analgesia, fewer side effects, and lower need for rescue opioids compared to IV fentanyl. Additionally, FNB has shown an effective and safe pain control in patients with cognitive impairment compared to patients without cognitive impairment.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06862154.
参考来源
- Altunbaş E, Kudu E, Unal E, et al. Femoral nerve block vs IV fentanyl for hip fracture pain in the emergency department: A randomized double-blind clinical trial. Am J Emerg Med. 2025. PMID: 41167010. doi:10.1016/j.ajem.2025.10.044
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。